ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.990
+0.050 (2.58%)
Nov 22, 2024, 4:00 PM EST - Market closed
ADC Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 192 | 134 | 307 | 1,550 | 2,485 | - | |
| Market Cap Growth | 320.32% | -56.31% | -80.20% | -37.60% | - | - | |
| Enterprise Value | 373 | 259 | 264 | 1,340 | 2,030 | - | |
| Last Close Price | 1.99 | 1.66 | 3.84 | 20.20 | 32.01 | - | |
| PS Ratio | 2.57 | 1.93 | 1.46 | 45.71 | - | - | |
| PB Ratio | -1.77 | -0.90 | 3.86 | 9.34 | 7.41 | - | |
| P/TBV Ratio | - | - | 3.86 | 10.12 | 7.64 | - | |
| EV/Sales Ratio | 5.27 | 3.73 | 1.26 | 39.51 | - | - | |
| Debt / Equity Ratio | -2.64 | -2.89 | 4.15 | 1.97 | 0.12 | 0.05 | |
| Asset Turnover | 0.17 | 0.16 | 0.38 | 0.06 | - | 0.02 | |
| Inventory Turnover | 6.73 | 9.18 | 16.36 | - | - | - | |
| Quick Ratio | 4.41 | 4.49 | 4.87 | 6.74 | 10.90 | 5.86 | |
| Current Ratio | 4.92 | 4.97 | 5.31 | 7.10 | 11.14 | 6.15 | |
| Return on Equity (ROE) | - | - | -127.99% | -91.72% | -110.28% | -98.13% | |
| Return on Assets (ROA) | -21.17% | -24.54% | -13.90% | -28.91% | -42.04% | -51.78% | |
| Return on Capital (ROIC) | -26.01% | -30.12% | -17.08% | -37.57% | -55.48% | -61.56% | |
| Earnings Yield | -110.26% | -179.01% | -51.19% | -14.84% | -9.91% | - | |
| FCF Yield | -70.02% | -90.91% | -45.28% | -15.27% | -6.82% | - | |
| Buyback Yield / Dilution | -12.44% | -4.55% | -1.83% | -17.33% | -32.73% | -5.75% | |
| Total Shareholder Return | -12.44% | -4.55% | -1.83% | -17.33% | -32.73% | -5.75% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.